| Code | Display |
| A | ALIMENTARY TRACT AND METABOLISM |
| A01 | STOMATOLOGICAL PREPARATIONS |
| A01A | STOMATOLOGICAL PREPARATIONS |
| A01AA | Caries prophylactic agents |
| A01AA01 | sodium fluoride |
| A01AA02 | sodium monofluorophosphate |
| A01AA03 | olaflur |
| A01AA04 | stannous fluoride |
| A01AA30 | combinations |
| A01AA51 | sodium fluoride, combinations |
| A01AB | Antiinfectives and antiseptics for local oral treatment |
| A01AB02 | hydrogen peroxide |
| A01AB03 | chlorhexidine |
| A01AB04 | amphotericin B |
| A01AB05 | polynoxylin |
| A01AB06 | domiphen |
| A01AB07 | oxyquinoline |
| A01AB08 | neomycin |
| A01AB09 | miconazole |
| A01AB10 | natamycin |
| A01AB11 | various |
| A01AB12 | hexetidine |
| A01AB13 | tetracycline |
| A01AB14 | benzoxonium chloride |
| A01AB15 | tibezonium iodide |
| A01AB16 | mepartricin |
| A01AB17 | metronidazole |
| A01AB18 | clotrimazole |
| A01AB19 | sodium perborate |
| A01AB21 | chlortetracycline |
| A01AB22 | doxycycline |
| A01AB23 | minocycline |
| A01AB24 | octenidine |
| A01AB25 | oxytetracycline |
| A01AB53 | chlorhexidine and cetylpyridinium |
| A01AC | Corticosteroids for local oral treatment |
| A01AC01 | triamcinolone |
| A01AC02 | dexamethasone |
| A01AC03 | hydrocortisone |
| A01AC04 | prednisolone |
| A01AC54 | prednisolone, combinations |
| A01AD | Other agents for local oral treatment |
| A01AD01 | epinephrine |
| A01AD02 | benzydamine |
| A01AD05 | acetylsalicylic acid |
| A01AD06 | adrenalone |
| A01AD07 | amlexanox |
| A01AD08 | becaplermin |
| A01AD11 | various |
| A02 | DRUGS FOR ACID RELATED DISORDERS |
| A02A | ANTACIDS |
| A02AA | Magnesium compounds |
| A02AA01 | magnesium carbonate |
| A02AA02 | magnesium oxide |
| A02AA03 | magnesium peroxide |
| A02AA04 | magnesium hydroxide |
| A02AA05 | magnesium silicate |
| A02AA10 | combinations |
| A02AB | Aluminium compounds |
| A02AB01 | aluminium hydroxide |
| A02AB02 | algeldrate |
| A02AB03 | aluminium phosphate |
| A02AB04 | dihydroxialumini sodium carbonate |
| A02AB05 | aluminium acetoacetate |
| A02AB06 | aloglutamol |
| A02AB07 | aluminium glycinate |
| A02AB10 | combinations |
| A02AC | Calcium compounds |
| A02AC01 | calcium carbonate |
| A02AC02 | calcium silicate |
| A02AC10 | combinations |
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds |
| A02AD01 | ordinary salt combinations |
| A02AD02 | magaldrate |
| A02AD03 | almagate |
| A02AD04 | hydrotalcite |
| A02AD05 | almasilate |
| A02AF | Antacids with antiflatulents |
| A02AF01 | magaldrate and antiflatulents |
| A02AF02 | ordinary salt combinations and antiflatulents |
| A02AG | Antacids with antispasmodics |
| A02AH | Antacids with sodium bicarbonate |
| A02AX | Antacids, other combinations |
| A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) |
| A02BA | H2-receptor antagonists |
| A02BA01 | cimetidine |
| A02BA02 | ranitidine |
| A02BA03 | famotidine |
| A02BA04 | nizatidine |
| A02BA05 | niperotidine |
| A02BA06 | roxatidine |
| A02BA07 | ranitidine bismuth citrate |
| A02BA08 | lafutidine |
| A02BA51 | cimetidine, combinations |
| A02BA53 | famotidine, combinations |
| A02BB | Prostaglandins |
| A02BB01 | misoprostol |
| A02BB02 | enprostil |
| A02BC | Proton pump inhibitors |
| A02BC01 | omeprazole |
| A02BC02 | pantoprazole |
| A02BC03 | lansoprazole |
| A02BC04 | rabeprazole |
| A02BC05 | esomeprazole |
| A02BC06 | dexlansoprazole |
| A02BC07 | dexrabeprazole |
| A02BC08 | vonoprazan |
| A02BC09 | tegoprazan |
| A02BC10 | fexuprazan |
| A02BC11 | ilaprazole |
| A02BC51 | omeprazole, combinations |
| A02BC53 | lansoprazole, combinations |
| A02BC54 | rabeprazole, combinations |
| A02BD | Combinations for eradication of Helicobacter pylori |
| A02BD01 | omeprazole, amoxicillin and metronidazole |
| A02BD02 | lansoprazole, tetracycline and metronidazole |
| A02BD03 | lansoprazole, amoxicillin and metronidazole |
| A02BD04 | pantoprazole, amoxicillin and clarithromycin |
| A02BD05 | omeprazole, amoxicillin and clarithromycin |
| A02BD06 | esomeprazole, amoxicillin and clarithromycin |
| A02BD07 | lansoprazole, amoxicillin and clarithromycin |
| A02BD08 | bismuth subcitrate, tetracycline and metronidazole |
| A02BD09 | lansoprazole, clarithromycin and tinidazole |
| A02BD10 | lansoprazole, amoxicillin and levofloxacin |
| A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole |
| A02BD12 | rabeprazole, amoxicillin and clarithromycin |
| A02BD13 | rabeprazole, amoxicillin and metronidazole |
| A02BD14 | vonoprazan, amoxicillin and clarithromycin |
| A02BD15 | vonoprazan, amoxicillin and metronidazole |
| A02BD16 | omeprazole, amoxicillin and rifabutin |
| A02BD17 | vonoprazan and amoxicillin |
| A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| A02BX01 | carbenoxolone |
| A02BX02 | sucralfate |
| A02BX03 | pirenzepine |
| A02BX04 | methiosulfonium chloride |
| A02BX05 | bismuth subcitrate |
| A02BX06 | proglumide |
| A02BX07 | gefarnate |
| A02BX08 | sulglicotide |
| A02BX09 | acetoxolone |
| A02BX10 | zolimidine |
| A02BX11 | troxipide |
| A02BX12 | bismuth subnitrate |
| A02BX13 | alginic acid |
| A02BX14 | rebamipide |
| A02BX15 | teprenone |
| A02BX16 | irsogladine |
| A02BX51 | carbenoxolone, combinations excl. psycholeptics |
| A02BX71 | carbenoxolone, combinations with psycholeptics |
| A02BX77 | gefarnate, combinations with psycholeptics |
| A02X | OTHER DRUGS FOR ACID RELATED DISORDERS |
| A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| A03AA | Synthetic anticholinergics, esters with tertiary amino group |
| A03AA01 | oxyphencyclimine |
| A03AA03 | camylofin |
| A03AA04 | mebeverine |
| A03AA05 | trimebutine |
| A03AA06 | rociverine |
| A03AA07 | dicycloverine |
| A03AA08 | dihexyverine |
| A03AA09 | difemerine |
| A03AA30 | piperidolate |
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds |
| A03AB01 | benzilone |
| A03AB02 | glycopyrronium bromide |
| A03AB03 | oxyphenonium |
| A03AB04 | penthienate |
| A03AB05 | propantheline |
| A03AB06 | otilonium bromide |
| A03AB07 | methantheline |
| A03AB08 | tridihexethyl |
| A03AB09 | isopropamide |
| A03AB10 | hexocyclium |
| A03AB11 | poldine |
| A03AB12 | mepenzolate |
| A03AB13 | bevonium |
| A03AB14 | pipenzolate |
| A03AB15 | diphemanil |
| A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide |
| A03AB17 | tiemonium iodide |
| A03AB18 | prifinium bromide |
| A03AB19 | timepidium bromide |
| A03AB21 | fenpiverinium |
| A03AB53 | oxyphenonium, combinations |
| A03AC | Synthetic antispasmodics, amides with tertiary amines |
| A03AC02 | dimethylaminopropionylphenothiazine |
| A03AC04 | nicofetamide |
| A03AC05 | tiropramide |
| A03AD | Papaverine and derivatives |
| A03AD01 | papaverine |
| A03AD02 | drotaverine |
| A03AD30 | moxaverine |
| A03AE | Serotonin receptor antagonists |
| A03AE01 | alosetron |
| A03AE03 | cilansetron |
| A03AX | Other drugs for functional gastrointestinal disorders |
| A03AX01 | fenpiprane |
| A03AX02 | diisopromine |
| A03AX03 | chlorbenzoxamine |
| A03AX04 | pinaverium |
| A03AX05 | fenoverine |
| A03AX06 | idanpramine |
| A03AX07 | proxazole |
| A03AX08 | alverine |
| A03AX09 | trepibutone |
| A03AX10 | isometheptene |
| A03AX11 | caroverine |
| A03AX12 | phloroglucinol |
| A03AX13 | silicones |
| A03AX14 | valethamate |
| A03AX15 | menthae piperitae aetheroleum |
| A03AX30 | trimethyldiphenylpropylamine |
| A03AX58 | alverine, combinations |
| A03B | BELLADONNA AND DERIVATIVES, PLAIN |
| A03BA | Belladonna alkaloids, tertiary amines |
| A03BA01 | atropine |
| A03BA03 | hyoscyamine |
| A03BA04 | belladonna total alkaloids |
| A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| A03BB01 | butylscopolamine |
| A03BB02 | methylatropine |
| A03BB03 | methylscopolamine |
| A03BB04 | fentonium |
| A03BB05 | cimetropium bromide |
| A03BB06 | homatropine methylbromide |
| A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS |
| A03CA | Synthetic anticholinergic agents in combination with psycholeptics |
| A03CA01 | isopropamide and psycholeptics |
| A03CA02 | clidinium and psycholeptics |
| A03CA03 | oxyphencyclimine and psycholeptics |
| A03CA04 | otilonium bromide and psycholeptics |
| A03CA05 | glycopyrronium bromide and psycholeptics |
| A03CA06 | bevonium and psycholeptics |
| A03CA07 | ambutonium and psycholeptics |
| A03CA08 | diphemanil and psycholeptics |
| A03CA09 | pipenzolate and psycholeptics |
| A03CA30 | emepronium and psycholeptics |
| A03CA34 | propantheline and psycholeptics |
| A03CB | Belladonna and derivatives in combination with psycholeptics |
| A03CB01 | methylscopolamine and psycholeptics |
| A03CB02 | belladonna total alkaloids and psycholeptics |
| A03CB03 | atropine and psycholeptics |
| A03CB04 | homatropine methylbromide and psycholeptics |
| A03CB31 | hyoscyamine and psycholeptics |
| A03CC | Other antispasmodics in combination with psycholeptics |
| A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS |
| A03DA | Synthetic anticholinergic agents in combination with analgesics |
| A03DA01 | tropenzilone and analgesics |
| A03DA02 | pitofenone and analgesics |
| A03DA03 | bevonium and analgesics |
| A03DA04 | ciclonium and analgesics |
| A03DA05 | camylofin and analgesics |
| A03DA06 | trospium and analgesics |
| A03DA07 | tiemonium iodide and analgesics |
| A03DB | Belladonna and derivatives in combination with analgesics |
| A03DB04 | butylscopolamine and analgesics |
| A03DC | Other antispasmodics in combination with analgesics |
| A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS |
| A03EA | Antispasmodics, psycholeptics and analgesics in combination |
| A03ED | Antispasmodics in combination with other drugs |
| A03F | PROPULSIVES |
| A03FA | Propulsives |
| A03FA01 | metoclopramide |
| A03FA02 | cisapride |
| A03FA03 | domperidone |
| A03FA04 | bromopride |
| A03FA05 | alizapride |
| A03FA06 | clebopride |
| A03FA07 | itopride |
| A03FA08 | cinitapride |
| A03FA09 | mosapride |
| A03FA10 | acotiamide |
| A04 | ANTIEMETICS AND ANTINAUSEANTS |
| A04A | ANTIEMETICS AND ANTINAUSEANTS |
| A04AA | Serotonin (5HT3) antagonists |
| A04AA01 | ondansetron |
| A04AA02 | granisetron |
| A04AA03 | tropisetron |
| A04AA04 | dolasetron |
| A04AA05 | palonosetron |
| A04AA55 | palonosetron, combinations |
| A04AD | Other antiemetics |
| A04AD01 | scopolamine |
| A04AD02 | cerium oxalate |
| A04AD04 | chlorobutanol |
| A04AD05 | metopimazine |
| A04AD10 | dronabinol |
| A04AD11 | nabilone |
| A04AD12 | aprepitant |
| A04AD13 | casopitant |
| A04AD14 | rolapitant |
| A04AD51 | scopolamine, combinations |
| A04AD54 | chlorobutanol, combinations |
| A05 | BILE AND LIVER THERAPY |
| A05A | BILE THERAPY |
| A05AA | Bile acids and derivatives |
| A05AA01 | chenodeoxycholic acid |
| A05AA02 | ursodeoxycholic acid |
| A05AA03 | cholic acid |
| A05AA04 | obeticholic acid |
| A05AA05 | ursodoxicoltaurine |
| A05AB | Preparations for biliary tract therapy |
| A05AB01 | nicotinyl methylamide |
| A05AX | Other drugs for bile therapy |
| A05AX01 | piprozolin |
| A05AX02 | hymecromone |
| A05AX03 | cyclobutyrol |
| A05AX04 | maralixibat chloride |
| A05AX05 | odevixibat |
| A05AX06 | elafibranor |
| A05AX07 | seladelpar |
| A05B | LIVER THERAPY, LIPOTROPICS |
| A05BA | Liver therapy |
| A05BA01 | arginine glutamate |
| A05BA03 | silymarin |
| A05BA04 | citiolone |
| A05BA05 | epomediol |
| A05BA06 | ornithine oxoglurate |
| A05BA07 | tidiacic arginine |
| A05BA08 | glycyrrhizic acid |
| A05BA09 | metadoxine |
| A05BA10 | phospholipids |
| A05C | DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION |
| A06 | DRUGS FOR CONSTIPATION |
| A06A | DRUGS FOR CONSTIPATION |
| A06AA | Softeners, emollients |
| A06AA01 | liquid paraffin |
| A06AA02 | docusate sodium |
| A06AA51 | liquid paraffin, combinations |
| A06AB | Contact laxatives |
| A06AB01 | oxyphenisatine |
| A06AB02 | bisacodyl |
| A06AB03 | dantron |
| A06AB04 | phenolphthalein |
| A06AB05 | castor oil |
| A06AB06 | senna glycosides |
| A06AB07 | cascara |
| A06AB08 | sodium picosulfate |
| A06AB09 | bisoxatin |
| A06AB20 | contact laxatives in combination |
| A06AB30 | contact laxatives in combination with belladonna alkaloids |
| A06AB52 | bisacodyl, combinations |
| A06AB53 | dantron, combinations |
| A06AB56 | senna glycosides, combinations |
| A06AB57 | cascara, combinations |
| A06AB58 | sodium picosulfate, combinations |
| A06AC | Bulk-forming laxatives |
| A06AC01 | ispaghula (psylla seeds) |
| A06AC02 | ethulose |
| A06AC03 | sterculia |
| A06AC05 | linseed |
| A06AC06 | methylcellulose |
| A06AC07 | triticum (wheat fibre) |
| A06AC08 | polycarbophil calcium |
| A06AC51 | ispaghula, combinations |
| A06AC53 | sterculia, combinations |
| A06AC55 | linseed, combinations |
| A06AD | Osmotically acting laxatives |
| A06AD01 | magnesium carbonate |
| A06AD02 | magnesium oxide |
| A06AD03 | magnesium peroxide |
| A06AD04 | magnesium sulfate |
| A06AD10 | mineral salts in combination |
| A06AD11 | lactulose |
| A06AD12 | lactitol |
| A06AD13 | sodium sulfate |
| A06AD14 | pentaerithrityl |
| A06AD15 | macrogol |
| A06AD16 | mannitol |
| A06AD17 | sodium phosphate |
| A06AD18 | sorbitol |
| A06AD19 | magnesium citrate |
| A06AD21 | sodium tartrate |
| A06AD61 | lactulose, combinations |
| A06AD65 | macrogol, combinations |
| A06AG | Enemas |
| A06AG01 | sodium phosphate |
| A06AG02 | bisacodyl |
| A06AG03 | dantron, incl. combinations |
| A06AG04 | glycerol |
| A06AG06 | oil |
| A06AG07 | sorbitol |
| A06AG10 | docusate sodium, incl. combinations |
| A06AG11 | sodium lauryl sulfoacetate, incl. combinations |
| A06AG20 | combinations |
| A06AH | Peripheral opioid receptor antagonists |
| A06AH01 | methylnaltrexone bromide |
| A06AH02 | alvimopan |
| A06AH03 | naloxegol |
| A06AH04 | naloxone |
| A06AH05 | naldemedine |
| A06AX | Other drugs for constipation |
| A06AX01 | glycerol |
| A06AX02 | carbon dioxide producing drugs |
| A06AX03 | lubiprostone |
| A06AX04 | linaclotide |
| A06AX05 | prucalopride |
| A06AX06 | tegaserod |
| A06AX07 | plecanatide |
| A06AX08 | tenapanor |
| A06AX09 | elobixibat |
| A07 | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS |
| A07A | INTESTINAL ANTIINFECTIVES |
| A07AA | Antibiotics |
| A07AA01 | neomycin |
| A07AA02 | nystatin |
| A07AA03 | natamycin |
| A07AA04 | streptomycin |
| A07AA05 | polymyxin B |
| A07AA06 | paromomycin |
| A07AA07 | amphotericin B |
| A07AA08 | kanamycin |
| A07AA09 | vancomycin |
| A07AA10 | colistin |
| A07AA11 | rifaximin |
| A07AA12 | fidaxomicin |
| A07AA13 | rifamycin |
| A07AA51 | neomycin, combinations |
| A07AA54 | streptomycin, combinations |
| A07AB | Sulfonamides |
| A07AB02 | phthalylsulfathiazole |
| A07AB03 | sulfaguanidine |
| A07AB04 | succinylsulfathiazole |
| A07AC | Imidazole derivatives |
| A07AC01 | miconazole |
| A07AX | Other intestinal antiinfectives |
| A07AX01 | broxyquinoline |
| A07AX02 | acetarsol |
| A07AX03 | nifuroxazide |
| A07AX04 | nifurzide |
| A07B | INTESTINAL ADSORBENTS |
| A07BA | Charcoal preparations |
| A07BA01 | medicinal charcoal |
| A07BA51 | medicinal charcoal, combinations |
| A07BB | Bismuth preparations |
| A07BC | Other intestinal adsorbents |
| A07BC01 | pectin |
| A07BC02 | kaolin |
| A07BC03 | crospovidone |
| A07BC04 | attapulgite |
| A07BC05 | diosmectite |
| A07BC30 | combinations |
| A07BC54 | attapulgite, combinations |
| A07C | ELECTROLYTES WITH CARBOHYDRATES |
| A07CA | Oral rehydration salt formulations |
| A07D | ANTIPROPULSIVES |
| A07DA | Antipropulsives |
| A07DA01 | diphenoxylate |
| A07DA02 | opium |
| A07DA03 | loperamide |
| A07DA04 | difenoxin |
| A07DA05 | loperamide oxide |
| A07DA06 | eluxadoline |
| A07DA52 | morphine, combinations |
| A07DA53 | loperamide, combinations |
| A07E | INTESTINAL ANTIINFLAMMATORY AGENTS |
| A07EA | Corticosteroids acting locally |
| A07EA01 | prednisolone |
| A07EA02 | hydrocortisone |
| A07EA03 | prednisone |
| A07EA04 | betamethasone |
| A07EA05 | tixocortol |
| A07EA06 | budesonide |
| A07EA07 | beclometasone |
| A07EB | Antiallergic agents, excl. corticosteroids |
| A07EB01 | cromoglicic acid |
| A07EC | Aminosalicylic acid and similar agents |
| A07EC01 | sulfasalazine |
| A07EC02 | mesalazine |
| A07EC03 | olsalazine |
| A07EC04 | balsalazide |
| A07F | ANTIDIARRHEAL MICROORGANISMS |
| A07FA | Antidiarrheal microorganisms |
| A07FA01 | lactic acid producing organisms |
| A07FA02 | saccharomyces boulardii |
| A07FA03 | escherichia coli |
| A07FA51 | lactic acid producing organisms, combinations |
| A07X | OTHER ANTIDIARRHEALS |
| A07XA | Other antidiarrheals |
| A07XA01 | albumin tannate |
| A07XA02 | ceratonia |
| A07XA03 | calcium compounds |
| A07XA04 | racecadotril |
| A07XA06 | crofelemer |
| A07XA51 | albumin tannate, combinations |
| A08 | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08A | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| A08AA | Centrally acting antiobesity products |
| A08AA01 | phentermine |
| A08AA02 | fenfluramine |
| A08AA03 | amfepramone |
| A08AA04 | dexfenfluramine |
| A08AA05 | mazindol |
| A08AA06 | etilamfetamine |
| A08AA07 | cathine |
| A08AA08 | clobenzorex |
| A08AA09 | mefenorex |
| A08AA10 | sibutramine |
| A08AA11 | lorcaserin |
| A08AA12 | setmelanotide |
| A08AA51 | phentermine and topiramate |
| A08AA56 | ephedrine, combinations |
| A08AA62 | bupropion and naltrexone |
| A08AB | Peripherally acting antiobesity products |
| A08AB01 | orlistat |
| A08AX | Other antiobesity drugs |
| A08AX01 | rimonabant |
| A09 | DIGESTIVES, INCL. ENZYMES |
| A09A | DIGESTIVES, INCL. ENZYMES |
| A09AA | Enzyme preparations |
| A09AA01 | diastase |
| A09AA02 | multienzymes (lipase, protease etc.) |
| A09AA03 | pepsin |
| A09AA04 | tilactase |
| A09AB | Acid preparations |
| A09AB01 | glutamic acid hydrochloride |
| A09AB02 | betaine hydrochloride |
| A09AB03 | hydrochloric acid |
| A09AB04 | citric acid |
| A09AC | Enzyme and acid preparations, combinations |
| A09AC01 | pepsin and acid preparations |
| A09AC02 | multienzymes and acid preparations |
| A10 | DRUGS USED IN DIABETES |
| A10A | INSULINS AND ANALOGUES |
| A10AB | Insulins and analogues for injection, fast-acting |
| A10AB01 | insulin (human) |
| A10AB02 | insulin (beef) |
| A10AB03 | insulin (pork) |
| A10AB04 | insulin lispro |
| A10AB05 | insulin aspart |
| A10AB06 | insulin glulisine |
| A10AB30 | combinations |
| A10AC | Insulins and analogues for injection, intermediate-acting |
| A10AC01 | insulin (human) |
| A10AC02 | insulin (beef) |
| A10AC03 | insulin (pork) |
| A10AC04 | insulin lispro |
| A10AC30 | combinations |
| A10AD | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting |
| A10AD01 | insulin (human) |
| A10AD02 | insulin (beef) |
| A10AD03 | insulin (pork) |
| A10AD04 | insulin lispro |
| A10AD05 | insulin aspart |
| A10AD06 | insulin degludec and insulin aspart |
| A10AD30 | combinations |
| A10AE | Insulins and analogues for injection, long-acting |
| A10AE01 | insulin (human) |
| A10AE02 | insulin (beef) |
| A10AE03 | insulin (pork) |
| A10AE04 | insulin glargine |
| A10AE05 | insulin detemir |
| A10AE06 | insulin degludec |
| A10AE07 | insulin icodec |
| A10AE30 | combinations |
| A10AE54 | insulin glargine and lixisenatide |
| A10AE56 | insulin degludec and liraglutide |
| A10AF | Insulins and analogues for inhalation |
| A10AF01 | insulin (human) |
| A10B | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| A10BA | Biguanides |
| A10BA01 | phenformin |
| A10BA02 | metformin |
| A10BA03 | buformin |
| A10BB | Sulfonylureas |
| A10BB01 | glibenclamide |
| A10BB02 | chlorpropamide |
| A10BB03 | tolbutamide |
| A10BB04 | glibornuride |
| A10BB05 | tolazamide |
| A10BB06 | carbutamide |
| A10BB07 | glipizide |
| A10BB08 | gliquidone |
| A10BB09 | gliclazide |
| A10BB10 | metahexamide |
| A10BB11 | glisoxepide |
| A10BB12 | glimepiride |
| A10BB31 | acetohexamide |
| A10BC | Sulfonamides (heterocyclic) |
| A10BC01 | glymidine |
| A10BD | Combinations of oral blood glucose lowering drugs |
| A10BD01 | phenformin and sulfonylureas |
| A10BD02 | metformin and sulfonylureas |
| A10BD03 | metformin and rosiglitazone |
| A10BD04 | glimepiride and rosiglitazone |
| A10BD05 | metformin and pioglitazone |
| A10BD06 | glimepiride and pioglitazone |
| A10BD07 | metformin and sitagliptin |
| A10BD08 | metformin and vildagliptin |
| A10BD09 | pioglitazone and alogliptin |
| A10BD10 | metformin and saxagliptin |
| A10BD11 | metformin and linagliptin |
| A10BD12 | pioglitazone and sitagliptin |
| A10BD13 | metformin and alogliptin |
| A10BD14 | metformin and repaglinide |
| A10BD15 | metformin and dapagliflozin |
| A10BD16 | metformin and canagliflozin |
| A10BD17 | metformin and acarbose |
| A10BD18 | metformin and gemigliptin |
| A10BD19 | linagliptin and empagliflozin |
| A10BD20 | metformin and empagliflozin |
| A10BD21 | saxagliptin and dapagliflozin |
| A10BD22 | metformin and evogliptin |
| A10BD23 | metformin and ertugliflozin |
| A10BD24 | sitagliptin and ertugliflozin |
| A10BD25 | metformin, saxagliptin and dapagliflozin |
| A10BD26 | metformin and lobeglitazone |
| A10BD27 | metformin, linagliptin and empagliflozin |
| A10BD28 | metformin and teneligliptin |
| A10BD29 | sitagliptin and dapagliflozin |
| A10BD30 | gemigliptin and dapagliflozin |
| A10BF | Alpha glucosidase inhibitors |
| A10BF01 | acarbose |
| A10BF02 | miglitol |
| A10BF03 | voglibose |
| A10BG | Thiazolidinediones |
| A10BG01 | troglitazone |
| A10BG02 | rosiglitazone |
| A10BG03 | pioglitazone |
| A10BG04 | lobeglitazone |
| A10BH | Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| A10BH01 | sitagliptin |
| A10BH02 | vildagliptin |
| A10BH03 | saxagliptin |
| A10BH04 | alogliptin |
| A10BH05 | linagliptin |
| A10BH06 | gemigliptin |
| A10BH07 | evogliptin |
| A10BH08 | teneligliptin |
| A10BH51 | sitagliptin and simvastatin |
| A10BH52 | gemigliptin and rosuvastatin |
| A10BJ | Glucagon-like peptide-1 (GLP-1) analogues |
| A10BJ01 | exenatide |
| A10BJ02 | liraglutide |
| A10BJ03 | lixisenatide |
| A10BJ04 | albiglutide |
| A10BJ05 | dulaglutide |
| A10BJ06 | semaglutide |
| A10BJ07 | beinaglutide |
| A10BK | Sodium-glucose co-transporter 2 (SGLT2) inhibitors |
| A10BK01 | dapagliflozin |
| A10BK02 | canagliflozin |
| A10BK03 | empagliflozin |
| A10BK04 | ertugliflozin |
| A10BK05 | ipragliflozin |
| A10BK06 | sotagliflozin |
| A10BK07 | luseogliflozin |
| A10BK08 | bexagliflozin |
| A10BK09 | enavogliflozin |
| A10BX | Other blood glucose lowering drugs, excl. insulins |
| A10BX01 | guar gum |
| A10BX02 | repaglinide |
| A10BX03 | nateglinide |
| A10BX05 | pramlintide |
| A10BX06 | benfluorex |
| A10BX08 | mitiglinide |
| A10BX15 | imeglimin |
| A10BX16 | tirzepatide |
| A10BX17 | carfloglitazar |
| A10BX18 | dorzagliatin |
| A10X | OTHER DRUGS USED IN DIABETES |
| A10XA | Aldose reductase inhibitors |
| A10XA01 | tolrestat |
| A10XX | Other drugs used in diabetes |
| A10XX01 | teplizumab |
| A10XX02 | donislecel |
| A11 | VITAMINS |
| A11A | MULTIVITAMINS, COMBINATIONS |
| A11AA | Multivitamins with minerals |
| A11AA01 | multivitamins and iron |
| A11AA02 | multivitamins and calcium |
| A11AA03 | multivitamins and other minerals, incl. combinations |
| A11AA04 | multivitamins and trace elements |
| A11AB | Multivitamins, other combinations |
| A11B | MULTIVITAMINS, PLAIN |
| A11BA | Multivitamins, plain |
| A11C | VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO |
| A11CA | Vitamin A, plain |
| A11CA01 | retinol (vit A) |
| A11CA02 | betacarotene |
| A11CB | Vitamin A and D in combination |
| A11CC | Vitamin D and analogues |
| A11CC01 | ergocalciferol |
| A11CC02 | dihydrotachysterol |
| A11CC03 | alfacalcidol |
| A11CC04 | calcitriol |
| A11CC05 | colecalciferol |
| A11CC06 | calcifediol |
| A11CC20 | combinations |
| A11CC55 | colecalciferol, combinations |
| A11D | VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 |
| A11DA | Vitamin B1, plain |
| A11DA01 | thiamine (vit B1) |
| A11DA02 | sulbutiamine |
| A11DA03 | benfotiamine |
| A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 |
| A11E | VITAMIN B-COMPLEX, INCL. COMBINATIONS |
| A11EA | Vitamin B-complex, plain |
| A11EB | Vitamin B-complex with vitamin C |
| A11EC | Vitamin B-complex with minerals |
| A11ED | Vitamin B-complex with anabolic steroids |
| A11EX | Vitamin B-complex, other combinations |
| A11G | ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS |
| A11GA | Ascorbic acid (vitamin C), plain |
| A11GA01 | ascorbic acid (vit C) |
| A11GB | Ascorbic acid (vitamin C), combinations |
| A11GB01 | ascorbic acid (vit C) and calcium |
| A11H | OTHER PLAIN VITAMIN PREPARATIONS |
| A11HA | Other plain vitamin preparations |
| A11HA01 | nicotinamide |
| A11HA02 | pyridoxine (vit B6) |
| A11HA03 | tocopherol (vit E) |
| A11HA04 | riboflavin (vit B2) |
| A11HA05 | biotin |
| A11HA06 | pyridoxal phosphate |
| A11HA07 | inositol |
| A11HA08 | tocofersolan |
| A11HA30 | dexpanthenol |
| A11HA31 | calcium pantothenate |
| A11HA32 | pantethine |
| A11J | OTHER VITAMIN PRODUCTS, COMBINATIONS |
| A11JA | Combinations of vitamins |
| A11JB | Vitamins with minerals |
| A11JC | Vitamins, other combinations |
| A12 | MINERAL SUPPLEMENTS |
| A12A | CALCIUM |
| A12AA | Calcium |
| A12AA01 | calcium phosphate |
| A12AA02 | calcium glubionate |
| A12AA03 | calcium gluconate |
| A12AA04 | calcium carbonate |
| A12AA05 | calcium lactate |
| A12AA06 | calcium lactate gluconate |
| A12AA07 | calcium chloride |
| A12AA08 | calcium glycerylphosphate |
| A12AA09 | calcium citrate lysine complex |
| A12AA10 | calcium glucoheptonate |
| A12AA11 | calcium pangamate |
| A12AA13 | calcium citrate |
| A12AA20 | calcium (different salts in combination) |
| A12AA30 | calcium laevulate |
| A12AX | Calcium, combinations with vitamin D and/or other drugs |
| A12B | POTASSIUM |
| A12BA | Potassium |
| A12BA01 | potassium chloride |
| A12BA02 | potassium citrate |
| A12BA03 | potassium hydrogentartrate |
| A12BA04 | potassium hydrogencarbonate |
| A12BA05 | potassium gluconate |
| A12BA30 | potassium (different salts in combination) |
| A12BA51 | potassium, combinations |
| A12C | OTHER MINERAL SUPPLEMENTS |
| A12CA | Sodium |
| A12CA01 | sodium chloride |
| A12CA02 | sodium sulfate |
| A12CB | Zinc |
| A12CB01 | zinc sulfate |
| A12CB02 | zinc gluconate |
| A12CB03 | zinc protein complex |
| A12CC | Magnesium |
| A12CC01 | magnesium chloride |
| A12CC02 | magnesium sulfate |
| A12CC03 | magnesium gluconate |
| A12CC04 | magnesium citrate |
| A12CC05 | magnesium aspartate |
| A12CC06 | magnesium lactate |
| A12CC07 | magnesium levulinate |
| A12CC08 | magnesium pidolate |
| A12CC09 | magnesium orotate |
| A12CC10 | magnesium oxide |
| A12CC30 | magnesium (different salts in combination) |
| A12CD | Fluoride |
| A12CD01 | sodium fluoride |
| A12CD02 | sodium monofluorophosphate |
| A12CD51 | fluoride, combinations |
| A12CE | Selenium |
| A12CE01 | sodium selenate |
| A12CE02 | sodium selenite |
| A12CX | Other mineral products |
| A13 | TONICS |
| A13A | TONICS |
| A14 | ANABOLIC AGENTS FOR SYSTEMIC USE |
| A14A | ANABOLIC STEROIDS |
| A14AA | Androstan derivatives |
| A14AA01 | androstanolone |
| A14AA02 | stanozolol |
| A14AA03 | metandienone |
| A14AA04 | metenolone |
| A14AA05 | oxymetholone |
| A14AA06 | quinbolone |
| A14AA07 | prasterone |
| A14AA08 | oxandrolone |
| A14AA09 | norethandrolone |
| A14AB | Estren derivatives |
| A14AB01 | nandrolone |
| A14AB02 | ethylestrenol |
| A14AB03 | oxabolone cipionate |
| A14B | OTHER ANABOLIC AGENTS |
| A15 | APPETITE STIMULANTS |
| A16 | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16A | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| A16AA | Amino acids and derivatives |
| A16AA01 | levocarnitine |
| A16AA02 | ademetionine |
| A16AA03 | glutamine |
| A16AA04 | mercaptamine |
| A16AA05 | carglumic acid |
| A16AA06 | betaine |
| A16AA07 | metreleptin |
| A16AB | Enzymes |
| A16AB01 | alglucerase |
| A16AB02 | imiglucerase |
| A16AB03 | agalsidase alfa |
| A16AB04 | agalsidase beta |
| A16AB05 | laronidase |
| A16AB06 | sacrosidase |
| A16AB07 | alglucosidase alfa |
| A16AB08 | galsulfase |
| A16AB09 | idursulfase |
| A16AB10 | velaglucerase alfa |
| A16AB11 | taliglucerase alfa |
| A16AB12 | elosulfase alfa |
| A16AB13 | asfotase alfa |
| A16AB14 | sebelipase alfa |
| A16AB15 | velmanase alfa |
| A16AB16 | idursulfase beta |
| A16AB17 | cerliponase alfa |
| A16AB18 | vestronidase alfa |
| A16AB19 | pegvaliase |
| A16AB20 | pegunigalsidase alfa |
| A16AB21 | atidarsagene autotemcel |
| A16AB22 | avalglucosidase alfa |
| A16AB23 | cipaglucosidase alfa |
| A16AB24 | pegzilarginase |
| A16AB25 | olipudase alfa |
| A16AB26 | eladocagene exuparvovec |
| A16AB27 | pabinafusp alfa |
| A16AX | Various alimentary tract and metabolism products |
| A16AX01 | thioctic acid |
| A16AX02 | anethole trithione |
| A16AX03 | sodium phenylbutyrate |
| A16AX04 | nitisinone |
| A16AX05 | zinc acetate |
| A16AX06 | miglustat |
| A16AX07 | sapropterin |
| A16AX08 | teduglutide |
| A16AX09 | glycerol phenylbutyrate |
| A16AX10 | eliglustat |
| A16AX11 | sodium benzoate |
| A16AX12 | trientine |
| A16AX13 | uridine triacetate |
| A16AX14 | migalastat |
| A16AX15 | telotristat |
| A16AX16 | givosiran |
| A16AX17 | triheptanoin |
| A16AX18 | lumasiran |
| A16AX19 | fosdenopterin |
| A16AX20 | lonafarnib |
| A16AX21 | elivaldogene autotemcel |
| A16AX22 | tiomolibdic acid |
| A16AX23 | leriglitazone |
| A16AX24 | govorestat |
| A16AX25 | nedosiran |
| A16AX30 | sodium benzoate and sodium phenylacetate |
| B | BLOOD AND BLOOD FORMING ORGANS |
| B01 | ANTITHROMBOTIC AGENTS |
| B01A | ANTITHROMBOTIC AGENTS |
| B01AA | Vitamin K antagonists |
| B01AA01 | dicoumarol |
| B01AA02 | phenindione |
| B01AA03 | warfarin |
| B01AA04 | phenprocoumon |
| B01AA07 | acenocoumarol |
| B01AA08 | ethyl biscoumacetate |
| B01AA09 | clorindione |
| B01AA10 | diphenadione |
| B01AA11 | tioclomarol |
| B01AA12 | fluindione |
| B01AB | Heparin group |
| B01AB01 | heparin |
| B01AB02 | antithrombin III |
| B01AB04 | dalteparin |
| B01AB05 | enoxaparin |
| B01AB06 | nadroparin |
| B01AB07 | parnaparin |
| B01AB08 | reviparin |
| B01AB09 | danaparoid |
| B01AB10 | tinzaparin |
| B01AB11 | sulodexide |
| B01AB12 | bemiparin |
| B01AB51 | heparin, combinations |
| B01AC | Platelet aggregation inhibitors excl. heparin |
| B01AC01 | ditazole |
| B01AC02 | cloricromen |
| B01AC03 | picotamide |
| B01AC04 | clopidogrel |
| B01AC05 | ticlopidine |
| B01AC06 | acetylsalicylic acid |
| B01AC07 | dipyridamole |
| B01AC08 | carbasalate calcium |
| B01AC09 | epoprostenol |
| B01AC10 | indobufen |
| B01AC11 | iloprost |
| B01AC13 | abciximab |
| B01AC15 | aloxiprin |
| B01AC16 | eptifibatide |
| B01AC17 | tirofiban |
| B01AC18 | triflusal |
| B01AC19 | beraprost |
| B01AC21 | treprostinil |
| B01AC22 | prasugrel |
| B01AC23 | cilostazol |
| B01AC24 | ticagrelor |
| B01AC25 | cangrelor |
| B01AC26 | vorapaxar |
| B01AC27 | selexipag |
| B01AC28 | limaprost |
| B01AC30 | combinations |
| B01AC56 | acetylsalicylic acid, combinations with proton pump inhibitors |
| B01AD | Enzymes |
| B01AD01 | streptokinase |
| B01AD02 | alteplase |
| B01AD03 | anistreplase |
| B01AD04 | urokinase |
| B01AD05 | fibrinolysin |
| B01AD06 | brinase |
| B01AD07 | reteplase |
| B01AD08 | saruplase |
| B01AD09 | ancrod |
| B01AD10 | drotrecogin alfa (activated) |
| B01AD11 | tenecteplase |
| B01AD12 | protein C |
| B01AD13 | apadamtase alfa and cinaxadamtase alfa |
| B01AE | Direct thrombin inhibitors |
| B01AE01 | desirudin |
| B01AE02 | lepirudin |
| B01AE03 | argatroban |
| B01AE04 | melagatran |
| B01AE05 | ximelagatran |
| B01AE06 | bivalirudin |
| B01AE07 | dabigatran etexilate |
| B01AF | Direct factor Xa inhibitors |
| B01AF01 | rivaroxaban |
| B01AF02 | apixaban |
| B01AF03 | edoxaban |
| B01AF04 | betrixaban |
| B01AF51 | rivaroxaban and acetylsalicylic acid |
| B01AX | Other antithrombotic agents |
| B01AX01 | defibrotide |
| B01AX04 | dermatan sulfate |
| B01AX05 | fondaparinux |
| B01AX07 | caplacizumab |
| B02 | ANTIHEMORRHAGICS |
| B02A | ANTIFIBRINOLYTICS |
| B02AA | Amino acids |
| B02AA01 | aminocaproic acid |
| B02AA02 | tranexamic acid |
| B02AA03 | aminomethylbenzoic acid |
| B02AB | Proteinase inhibitors |
| B02AB01 | aprotinin |
| B02AB02 | alfa1 antitrypsin |
| B02AB04 | camostat |
| B02AB05 | ulinastatin |
| B02B | VITAMIN K AND OTHER HEMOSTATICS |
| B02BA | Vitamin K |
| B02BA01 | phytomenadione |
| B02BA02 | menadione |
| B02BB | Fibrinogen |
| B02BB01 | fibrinogen, human |
| B02BC | Local hemostatics |
| B02BC01 | absorbable gelatin sponge |
| B02BC02 | oxidized cellulose |
| B02BC03 | tetragalacturonic acid hydroxymethylester |
| B02BC05 | adrenalone |
| B02BC06 | thrombin |
| B02BC07 | collagen |
| B02BC08 | calcium alginate |
| B02BC09 | epinephrine |
| B02BC30 | combinations |
| B02BD | Blood coagulation factors |
| B02BD01 | coagulation factor IX, II, VII and X in combination |
| B02BD02 | coagulation factor VIII |
| B02BD03 | factor VIII inhibitor bypassing activity |
| B02BD04 | coagulation factor IX |
| B02BD05 | coagulation factor VII |
| B02BD06 | von Willebrand factor and coagulation factor VIII in combination |
| B02BD07 | coagulation factor XIII |
| B02BD08 | coagulation factor VIIa |
| B02BD10 | von Willebrand factor |
| B02BD11 | catridecacog |
| B02BD13 | coagulation factor X |
| B02BD14 | susoctocog alfa |
| B02BD15 | valoctocogene roxaparvovec |
| B02BD16 | etranacogene dezaparvovec |
| B02BD17 | fidanacogene elaparvovec |
| B02BD30 | thrombin |
| B02BX | Other systemic hemostatics |
| B02BX01 | etamsylate |